US 9682976
Protein kinase C inhibitors and uses thereof
granted A61KA61K31/506A61K31/5377
Quick answer
US patent 9682976 (Protein kinase C inhibitors and uses thereof) held by Rigel Pharmaceuticals, Inc. expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 55
- CPC classes
- A61K, A61K31/506, A61K31/5377, A61K31/538, A61K31/5383